Danaher Corporation (NYSE: DHR), a provider of industrial and medical products, reported lower sales and net profit for the first quarter of 2023.
![](data:image/svg+xml;charset=utf-8,<svg height="1920px" width="1280px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
The first quarter net income was $1.43 billion, or $1.94 per share, compared to $1.68 billion or $2.31 per share in the same period of last year. Adjusted earnings decreased 14% year-over-year to $2.36 per share.
The bottom line was hurt by a 7% fall in net sales to $7.2 billion, mainly due to lower sales in the Diagnostics and Biotechnology segments.
